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Abstract
Dysautonomia in Guillain-Barre syn-
drome (GBS) rarely causes serious cardio-
vascular complications, such as sinus arrest.
Miller Fisher syndrome (MFS) is recog-
nized as a variant of GBS. There have been
few reports regarding the association
between MFS and dysautonomia. We
describe a case of a 68-year-old man with
ophthalmoplegia, bulbar palsy, truncal atax-
ia, and areflexia. He was diagnosed with
MFS because he exhibited the classical
clinical triad and had elevated serum anti-
GQ1b immunoglobulin G levels. A magnet-
ic resonance imaging scan of his head was
normal. His 24-hour Holter recording
showed sinus arrest. He was treated with
intravenous immunoglobulin, whereupon
his symptoms gradually improved. This
included the sinus arrest, which was consid-
ered a symptom of dysautonomia in MFS.
Therefore, clinicians should be mindful of
dysautonomia not only in GBS patients, but
also in cases of MFS.
Introduction
Dysautonomia is present in approxi-
mately two-third of patients with Guillain-
Barre syndrome (GBS).1 It results in a wide
range of symptoms, including various car-
diac arrhythmias. 
Although dysautonomia is usually of
minor clinical importance, it may cause life-
threatening cardiovascular complications.
Serious arrhythmias have been found in 7-
34% of GBS patients. Recent studies indi-
cate that these complications are not limited
to severely disabled patients who require
mechanical ventilation, but may also affect
those with milder forms of the condition,
who do not require artificial ventilation, and
are able to walk more than 5 meters.2,3
Miller Fisher syndrome (MFS) is recog-
nized as a variant of GBS. It is a relatively
rare condition that is characterized by the
acute onset of ophthalmoplegia, ataxia, and
areflexia or hyporeflexia.4,5 An association
between MFS and autonomic dysfunction
has been previously reported, with cardio-
vascular complications being rare.6,7 The
present case report describes sinus arrest in
a patient with MFS.
Case Report
A 68-year-old man had an acute onset
of truncal ataxia, dysarthria, and diplopia in
March 2009. He developed dysphagia the
next day and underwent a magnetic reso-
nance imaging (MRI) scan, which was nor-
mal. He presented to our neurology outpa-
tient department with truncal ataxia, opthal-
moplegia, and areflexia five days later.
Upon admission, he had a normal blood
pressure of 136/96 mmHg, a regular heart
rate of 98 beats per minute (bpm), and a
peripheral capillary oxygen saturation
(SpO2) of 97% in room air. Neurological
examination revealed mydriasis, absent
pupillary light reflex bilaterally, total oph-
thalmoplegia with both eyes fixed centrally,
bulbar palsy with nasal voice, dysphagia,
absent pharyngeal reflex, and absent deep
tendon reflexes. There was no limb weak-
ness. Finger-to nose and heel-to-shin tests
showed no dysmetria or decomposition.
Romberg’s test and Mann’s test were both
positive. He was unable to walk unaided
due to the truncal ataxia. There were no sen-
sory abnormalities, orthostatic hypotension,
and dysfunction of the bladder and bowel.
His blood count and serum biochemical
parameters were normal. Antinuclear, anti-
deoxyribonucleic acid (DNA), and anti-
acetylcholine receptor (Ach R) antibodies
were all negative. Vitamin B1 levels were
normal (46.3 ng/mL). Cerebrospinal fluid
analysis was normal with a cell count of
1/µL (mononuclear leukocytes), protein
level of 33 mg/dl, glucose level of 66 mg/dl
(serum glucose 97 mg/dl), and an IgG index
of 0.52. However, he tested positive for
serum anti-GQ1b IgG, an autoantigenic
antiganglioside antibody. His repeated head
MRI and chest X-rays were normal.
Given his presentation with acute onset
total ophthalmoplegia, ataxia, and areflexia,
he was diagnosed with MFS. He had a
Functional Systems Score (FSS) of 3 upon
admission. Treatment with intravenous
immunoglobulin (IVIG; 0.4 g/Kg body
weight/day for 5 days) was initiated on day
six. He underwent 24-hour Holter recording
on day seven because he had exhibited
bradycardia (heart rate under 40 bpm), sinus
arrest with the P wave falling off, and a
2.94-second duration of the greatest R-R
interval (Figure 1). There were five pauses
daily. The 24-hour Holter recording also
displayed atrioventricular dissociation with
junctional escape beats. After commencing
IVIG therapy, his bulbar palsy improved
first, followed by the internal ophthalmo-
plegia and truncal ataxia. In addition, a
repeat 24-hour Holter recording on day 19
showed that the sinus arrest had resolved.
He was discharged with an FSS of 2 on day
32. Approximately two months after the
onset of symptoms, the diplopia secondary
to the ophthalmoplegia had resolved.
Discussion
The present report described a classic
case of MFS defined by the acute onset of
ophthalmoplegia, ataxia, and areflexia, with
positive detection of serum anti-GQ1bIgG
antibody. The patient showed sinus arrest
early after the onset of his symptoms. The
sinus arrest, together with the other symp-
toms, improved soon after he had been
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commenced IVIG therapy. There was no
need for cardiac pacemaker insertion. 
Similarly to GBS, cardiovascular com-
plications are rarely reported in MFS and
are considered to be a complication of
dysautonomia.6,7 Kuzumoto et al. showed
an association between autonomic test
abnormality and anti-GQ1b antibody in
MFS.8 Recent studies on GBS indicate that
these complications are not only limited to
severely disabled patients who require
mechanical ventilation, but also affect those
with milder forms of the condition, who do
not require artificial ventilation and are able
to walk more than 5 meters.2,3 The degree of
motor impairment could not predict the
occurrence of serious bradyarrythmias,
including sinus arrest. Early recognition of
such life-threatening events is important so
that appropriate preventive measures, such
as the insertion of a cardiac pacemaker, can
be promptly taken. 
Conclusions
This report has shown that rare life-
threatening cardiovascular complications
may occur not only in GBS, but also in
MFS. 
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Figure 1. Holter recording on day seven displaying sinus arrest with P wave (arrow)
falling off, and 2.94 seconds at the greatest R-R interval. There were five pauses daily. 
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